These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19240026)

  • 1. Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation.
    Nemoto S; Nakamura M; Osawa Y; Kono S; Itoh Y; Okano Y; Murate T; Hara A; Ueda H; Nozawa Y; Banno Y
    J Biol Chem; 2009 Apr; 284(16):10422-32. PubMed ID: 19240026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
    Kawahara S; Otsuji Y; Nakamura M; Murakami M; Murate T; Matsunaga T; Kanoh H; Seishima M; Banno Y; Hara A
    Anticancer Drugs; 2013 Jun; 24(5):473-83. PubMed ID: 23426175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.
    Grbčić P; Eichmann TO; Kraljević Pavelić S; Sedić M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tyrosine phosphatase SHP2 promotes proliferation and oxaliplatin resistance of colon cancer cells through AKT and ERK.
    Yu M; Xu C; Zhang H; Lun J; Wang L; Zhang G; Fang J
    Biochem Biophys Res Commun; 2021 Jul; 563():1-7. PubMed ID: 34052504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR.
    Aoyama Y; Sobue S; Mizutani N; Inoue C; Kawamoto Y; Nishizawa Y; Ichihara M; Kyogashima M; Suzuki M; Nozawa Y; Murate T
    Biochem Biophys Res Commun; 2017 Apr; 486(2):551-557. PubMed ID: 28322796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway.
    Yu T; An Q; Cao XL; Yang H; Cui J; Li ZJ; Xiao G
    Life Sci; 2020 Nov; 260():118294. PubMed ID: 32818544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.
    Berdyshev EV; Gorshkova I; Skobeleva A; Bittman R; Lu X; Dudek SM; Mirzapoiazova T; Garcia JG; Natarajan V
    J Biol Chem; 2009 Feb; 284(9):5467-77. PubMed ID: 19119142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis.
    Sauane M; Su ZZ; Dash R; Liu X; Norris JS; Sarkar D; Lee SG; Allegood JC; Dent P; Spiegel S; Fisher PB
    J Cell Physiol; 2010 Mar; 222(3):546-55. PubMed ID: 19937735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
    Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
    J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide mediates nanovesicle shedding and cell death in response to phosphatidylinositol ether lipid analogs and perifosine.
    Gills JJ; Zhang C; Abu-Asab MS; Castillo SS; Marceau C; LoPiccolo J; Kozikowski AP; Tsokos M; Goldkorn T; Dennis PA
    Cell Death Dis; 2012 Jul; 3(7):e340. PubMed ID: 22764099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
    Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F
    Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells.
    Yang YL; Ji C; Cheng L; He L; Lu CC; Wang R; Bi ZG
    Cancer Sci; 2012 Aug; 103(8):1538-45. PubMed ID: 22594559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.
    Jani TS; DeVecchio J; Mazumdar T; Agyeman A; Houghton JA
    J Biol Chem; 2010 Jun; 285(25):19162-72. PubMed ID: 20424169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells].
    Zhang Y; Sun XW; Xu JH; Lu H; Fan ZZ; Sun J; Zhang XX
    Zhong Xi Yi Jie He Xue Bao; 2012 Aug; 10(8):901-10. PubMed ID: 22883407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
    Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells.
    Liu MN; Liu AY; Du YJ; Pei FH; Wang XH; Chen J; Liu D; Liu BR
    Mol Med Rep; 2015 Jul; 12(1):1189-96. PubMed ID: 25777765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism.
    Maceyka M; Sankala H; Hait NC; Le Stunff H; Liu H; Toman R; Collier C; Zhang M; Satin LS; Merrill AH; Milstien S; Spiegel S
    J Biol Chem; 2005 Nov; 280(44):37118-29. PubMed ID: 16118219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
    Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
    Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Anthraquinone Derivative C2 Enhances Oxaliplatin-Induced Cell Death and Triggers Autophagy via the PI3K/AKT/mTOR Pathway.
    Li Y; Yan W; Qin Y; Zhang L; Xiao S
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth.
    Zhang Y; Cheng L; Shi X; Song Y; Chen XY; Chen MB; Yao J; Zhang ZQ; Cai S
    Int J Biol Sci; 2022; 18(7):2994-3005. PubMed ID: 35541904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.